Retail Clinics In Store Healthcare Market Size, Share & Trends Analysis Report, By Location (Stores, Malls), Ownership Type (Retail Owned and Hospital Owned), Application (Clinical Chemistry & Immunoassay, Point of Care Diagnostics, Vaccination), By Region, Forecasts, 2025-2034
Retail Clinics in Store Healthcare Market is expected to grow at an 10.0% CAGR during the forecast period for 2025-2034. A retail clinic is a healthcare location that provides services and medications from a qualified clinician outside of a typical office or emergency department. Retail clinics do not have observation beds and are only open for walk-ins. The main advantage of these clinics is that no appointment is required to receive medical ...
Report ID: 1314 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 180
Lipid Nanodiscs Market Size, Share & Trends Analysis Report, By Type (Membrane Scaffold Protein (MSP) Nanodiscs and Synthetic Nanodiscs), By Application, By Region, And Segment Forecasts, 2025-2034
Lipid Nanodiscs Market is expected to grow at a 6.0% CAGR during the forecast period for 2025-2034. Lipids are a class of large chemical molecules classified as fatty acid derivatives or closely related compounds. Alcohols and other organic solvents are frequently better at solubilizing lipids than water. Nanodisc technology (NDT) has lately acquired appeal as a valuable tool for biochemical and molecular model systems of membrane proteins bec...
Report ID: 1342 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 1480
Tissue Engineering-based Regeneration Products Market Size, Share & Trends Analysis Report By Type of Graft (Allografts, Autografts, and Xenografts), By Area of Application, By Type of Material Scaffold, By End-User, By Region, And By Segment Forecasts, 2025-2034
Tissue Engineering-based Regeneration Products Market is expected to grow at a 10.5% CAGR during the forecast period for 2025-2034. Integrating scaffolds, cells, and biologically active chemicals to create functioning tissues is referred to as tissue engineering. Tissue engineering emerged from the field of biomaterials development and referred to the practice. Tissue engineering aims to put together functional constructions to repair, maintai...
Report ID: 1355 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 180
IVD Microsphere Market Forecasts 2025 to 2034
Global IVD Microsphere Market Size Was valued at USD 342.1 Mn in 2024 and is predicted to reach USD 618.7 Mn by 2034 at a 6.3% CAGR during the forecast period for 2025-2034. IVD Microsphere Market Size, Share & Trends Analysis Report, By Type (Magnetic Microspheres, Latex Microspheres, Fluorescent and Colored Microspheres, & Standard Microspheres and Others), By Application (Immunoturbidimetry, Immunochromatography, Chemiluminescen...
Report ID: 3050 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 170
TNF Biosimilars Market Size, Share & Trends Analysis Report By Drug (Adalimumab Biosimilar, Infliximab Biosimilar, Certolizumab Biosimilar, Etanercept Biosimilar, and Golimumab Biosimilar), By Distribution Channel (Online Pharmacy, Hospital Pharmacy, Retail Pharmacy), Region And Segment Forecasts, 2025-2034
TNF Biosimilars Market is expected to grow at a 16.5% CAGR during the forecast period for 2025-2034. Tumor necrosis factors are a group of cytokines that are secreted by macrophages and may induce cell death of certain tumor cell lines, which leads to inflammation. TNF inhibitors are the drug that stops inflammation. They are mainly indicated for the treatment of rheumatoid arthritis, psoriasis, inflammatory bowel disease, anklyosing Spo...
Report ID: 1072 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 180
Antibody Purification Services Market Size, Share & Trends Analysis Report By Antibody Types (Monoclonal, and Polyclonal), By Purification Methods, By End-Users, Region And Segment Forecasts, 2025-2034
Antibody Purification Services Market is expected to grow at an 10.5% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: Effective and targeted therapies are becoming more and more necessary due to the rising incidence of infectious and chronic illnesses. Pharmaceutical and biotechnology businesses are outsourcing antibody manufacturing and purification services more frequently in an e...
Report ID: 1248 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 180
Infliximab Biosimilar Market Size, Share & Trends Analysis Report By Brand, Applications (Crohn’s disease, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, ankylosing spondylitis, plaque psoriasis, and others), Distribution Channel, Region And Segment Forecasts, 2025-2034
Infliximab Biosimilar Market Size is valued at XX Million in 2024 and is predicted to reach XX Million by the year 2034 at an XX % CAGR during the forecast period for 2025-2034. Infliximab is chimeric anti-TNF monoclonal antibody approved for the treatment of Chron’s Disease. It is also approved for the treatment of other autoimmune diseases such as Psoriasis, rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, and others. It is...
Report ID: 1060 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 180
Filgrastim Biosimilars Market Size, Share & Trends Analysis Report By Application (Febrile Neutropenia, Genital Neutropenia, Idiopathic Neutropenia, and Others), By Distribution Channel (Online Pharmacy, Hospital Pharmacy, and Retail Pharmacy), Region And Segment Forecasts, 2023-2031
Filgrastim Biosimilars Market Size is predicted to expand with a 8.5% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: Governments around the world are promoting the use of biosimilars through various initiatives aimed at enhancing affordability and access. Filgrastim biosimilars have been shown to be effective and safe for managing neutropenia in cancer patients, which enhances their ado...
Report ID: 1076 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 175
Veterinary Antibiotics Market Size, Share & Trends Analysis Report By Product Type (Tetracyclines, Penicillins, Sulfonamides, Macrolides, Aminoglycosides, Lincosamides, Fluoroquinolones, Other Antimicrobials and Antibiotics, By Mode Of Delivery, By Animal Type, Region And Segment Forecasts, 2025-2034
Veterinary Antibiotics Market Size is valued at USD 4.99 Billion in 2024 and is predicted to reach USD 6.95 Billion by the year 2034 at a 3.5 % CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: The market is in great demand due to the increasing number of pet diseases worldwide, which leads to market growth. The need for efficient veterinary antibiotic treatments is driven by the rising in...
Report ID: 1128 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 180
Cancer Biosimilars Market Size, Share & Trends Analysis Report By Type (Lung Cancer, Breast cancer, Ovarian cancer, Prostate cancer, Lymphoma, Others), By Distribution Channel, By Drug Class, By Route of Administration, Region And Segment Forecasts, 2023-2031
The Cancer Biosimilars Market is expected to grow at a 20.0 % CAGR during the forecast period for 2023-2031. Biosimilar is defined as a type of biological product that is approved by respective regulatory bodies because of its clinical similarity to already approved biological products. This is relatively cheaper than biologics. The abnormal growth of call is called cancer. Cancer is the second leading cause of death across the globe. Ma...
Report ID: 1078 |
Delivery: Immediate |
Published: June 2025 |
No. of Pages: 180
Pharmaceuticals